Table of Contents
- Introduction to Phenylalanine
- Research Focus: Smoking and Cancer Prevention
- Study Design and Methodology
- Study Outcomes and Measurements
- Potential Implications for Smokers
Introduction to Phenylalanine
Phenylalanine is an essential amino acid that plays a crucial role in various bodily functions. In the context of the clinical trial discussed here, researchers are using a special form of phenylalanine called deuterated phenanthrene (abbreviated as [D10]phe) to study its metabolism in the body[1]. This modified version of phenylalanine is used as a tool to understand how certain compounds are processed in the bodies of current and former smokers.
Research Focus: Smoking and Cancer Prevention
The primary focus of this research is to explore potential ways to prevent tobacco-related lung cancer. Specifically, the study aims to determine whether consuming glucobrassicin-rich Brussels sprouts can favorably modify the metabolism of deuterated phenanthrene in current and former smokers[1]. This research is important because it may lead to food-based strategies for reducing the risk of lung cancer in individuals who have been exposed to tobacco smoke.
Study Design and Methodology
The study follows a specific protocol to assess the effects of Brussels sprouts on phenanthrene metabolism:
- Baseline measurement: Participants are given 1 microgram of [D10]phe, and their urine is collected for 6 hours to measure initial levels of certain metabolites[1].
- Brussels sprouts intervention: Within 3 days of the baseline measurement, participants consume 200 micromoles of glucobrassicin in the form of raw Brussels sprouts (approximately 200-300 grams) once daily for 7 consecutive days[1].
- Follow-up measurement: On the 7th day of the Brussels sprouts intervention, participants are given another 1 microgram dose of [D10]phe, followed by another 6-hour urine collection[1].
This design allows researchers to compare how the body processes phenanthrene before and after consuming Brussels sprouts for a week.
Study Outcomes and Measurements
The researchers are looking at several key outcomes to understand the effects of Brussels sprouts on phenanthrene metabolism:
- Primary outcome: Change in [D10]phenanthrene tetraol levels in urine before and after the Brussels sprouts intervention[1].
- Secondary outcomes:
- Other measurements: Levels of 3,3′-diindolylmethane (DIM) in urine, which is a compound produced when the body processes glucobrassicin from Brussels sprouts[1].
These measurements help researchers understand how Brussels sprouts might affect the way the body processes potentially harmful compounds found in tobacco smoke.
Potential Implications for Smokers
While this study doesn’t directly treat any diseases, it has important implications for current and former smokers:
- Cancer prevention: If Brussels sprouts are found to favorably modify the metabolism of phenanthrene, it could lead to dietary recommendations for reducing lung cancer risk in smokers and former smokers[1].
- Understanding tobacco-related health risks: The study provides insights into how the body processes compounds similar to those found in tobacco smoke, which could help in developing strategies to mitigate the harmful effects of smoking[1].
- Potential for food-based interventions: If successful, this research could pave the way for more studies on how dietary choices might help protect against the harmful effects of smoking[1].
It’s important to note that while this research is promising, it does not suggest that eating Brussels sprouts can make smoking safe. The best way to reduce the risk of tobacco-related lung cancer is to avoid smoking altogether.




